BioPharmSignal logoBioPharmSignal

Biotech News

Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026

Medpace (MEDP)MedpaceEarnings

CINCINNATI --(BUSINESS WIRE)--Sep. 22, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a conference call the following morning,

Related news

MEDPMedpace2025-09-23 20:05 EST

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

MEDPMedpace2026-06-16 20:23 EST

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

View all latest news

Medpace

Full-Service Clinical Research Medpace is a global contract research organization providing Phase 1 through Phase 4 clinical-development services to biotechnology, pharmaceutical and medical-device companies. Therapeutic and Scientific Expertise The company uses physician leadership and therapeutic-area specialists to support protocol...

Recent company news

MEDPMedpace2026-09-22 20:05 EST

Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026

MEDPMedpace2026-07-22 20:15 EST

Medpace Holdings, Inc. Reports Second Quarter 2026 Results

MEDPMedpace2026-06-16 20:23 EST

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026

MEDPMedpace2026-04-22 20:15 EST

Medpace Holdings, Inc. Reports First Quarter 2026 Results

MEDPMedpace2026-03-24 20:05 EST

Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026

Stock data

Close
599.47 USD
Market cap
12.73B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States